FRANKFURT (Reuters) - A BioNTech executive on Monday confirmed that the company is in discussions with Chinese authorities over regulatory approval of.
FRANKFURT (Reuters) - A BioNTech executive on Monday confirmed that the company is in discussions with Chinese authorities over regulatory approval of.